Dr. Lipkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Women's Malignancies Branch, National Cancer Institute, NIH
Building 10, Room 4B54, 10 Center Drive
Bethesda, MD 20892Phone+1 240-760-6129Fax+1 240-541-4547- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1984 - 1987
- Weill Cornell MedicineClass of 1984
Certifications & Licensure
- MD State Medical License 1987 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen Ibanez, Duncan...> ;Nature Communications. 2024 Mar 30
- Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer.Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S Harrington, Soumya Korrapati, Yusuke Shibuya, Leah Henegar, Jeffrey B Kopp, Takeo Fujii, Stanley Lipkowitz, ...> ;Cancer Gene Therapy. 2024 Feb 29
- 1 citationsA Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma.Sarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, Margaret E Gatti-Mays, Nicole Houston, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Christina Burks, C...> ;The Oncologist. 2023 Oct 3
- Join now to see all
Press Mentions
- Behind the Study: How ONC201 Kills Breast Cancer CellsApril 22nd, 2022
- Panel Tells FDA to Keep Atezolizumab Approval in TNBCApril 28th, 2021
- ONC201 Kills Breast Cancer Cells in Vitro by Targeting MitochondriaMay 9th, 2018
- Join now to see all
Grant Support
- Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2010–2011
- CBL Proteins As Regulators Of Tyrosine Kinase SignalingNational Cancer Institute2010–2011
- Trail-Induced Cell Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci2009
- Identification Of Molecular Targets In Triple-Negative Breast CancerDivision Of Basic Sciences - Nci2009
- CBL Proteins As Regulators Of Tyrosine Kinase SignalingDivision Of Basic Sciences - Nci2009
- Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2008
- Identification Of Molecular Targets In Triple-Negative Breast CancerNational Cancer Institute2008
- Signal Transduction In Epithelial Cancer CellsNational Cancer Institute2007
- Signal Transduction In Epithelial Cancer CellsDivision Of Clinical Sciences - Nci2006
- Molecular Control Of Growth, Differentiation, And DeathDivision Of Clinical Sciences - Nci2001–2005
- Molecular Control Of Growth, Differentiation, And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1999–2000
- Molecular Control Of Growth, Differentiation And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1996–1998
Hospital Affiliations
- Walter Reed National Military Medical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: